
Health.Market March 10, 2021
Crypto or biotech – Both are high risk and high reward investments. Bob Teague, MD layouts out the pros and cons for investors battered by market uncertainty.
Crypto or biotech – Both are high risk and high reward investments. Bob Teague, MD layouts out the pros and cons for investors battered by market uncertainty.
A closer look at the funding vehicles driving the VC-backed health tech and biotech markets and the pitfalls for the average investor entering 2022
A look back on the year that was for the healthcare industry and peek ahead for the digital health market in 2022 as we enter year three of Covid-19.
Providing broad access to virtual care seems like an obvious thing to do. And it looks like CMS is at least considering this expansion. The Cartel is mighty, however, and the pushback could be great. The market seems to agree and is not very enthusiastic at the prospects of these firms.
Organizing healthcare products and services into three categories including biotech complex, information dependent services, and consumer and patient experience and self-care may help track performance and relative valuation. In the end, whether new tech brings clinical value is the open question.
Digital health has been setting records for raising money in the private markets through VC’s and other sources of private investment. The hype is enormous for unproven technologies. The dynamics in the public markets for digital health stocks, the few that exist, hasn’t been so consistently enthusiastic. This will sort itself out based on delivering of actual value to patients, consumers and shareholders.
This market is as bullish and as overbought as it has been in a couple of decades though the monetary and fiscal backdrop are much different now. The huge money is rotating this way and that as we continue to slosh the bull.
It was a strange week. The market was right about the numbers. When the predicted happened, not much happened at the headline level but there was quite a bit of movement under the surface of the market. Sloshing continues. The market is clearly leaning bullish. The risk is bearish.
This market is as bullish and as overbought as it has been in a couple of decades though the monetary and fiscal backdrop are much different now. The huge money is rotating this way and that as we continue to slosh the bull.
This market is as bullish and as overbought as it has been in a couple of decades though the monetary and fiscal backdrop are much different now. The huge money is rotating this way and that as we continue to slosh the bull.
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.